Infinity Pharmaceuticals Announces Termination Of Merger Agreement With MEI Pharma
Portfolio Pulse from Benzinga Newsdesk
The merger agreement between Infinity Pharmaceuticals and MEI Pharma has been terminated. This decision was made after MEI failed to obtain stockholder approval for the merger during a special meeting. MEI also faced an unsolicited public proposal from activist stockholders to acquire the company at a significant discount.
July 24, 2023 | 12:36 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Infinity Pharmaceuticals' planned merger with MEI Pharma has been cancelled. This could potentially affect Infinity's future growth plans.
The termination of the merger agreement could potentially disrupt Infinity Pharmaceuticals' future growth and expansion plans. This could lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100